Taiyen Biotech Co Ltd (1737) - Total Liabilities
Based on the latest financial reports, Taiyen Biotech Co Ltd (1737) has total liabilities worth NT$1.67 Billion TWD (≈ $52.60 Million USD) as of June 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore 1737 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Taiyen Biotech Co Ltd - Total Liabilities Trend (2003–2025)
This chart illustrates how Taiyen Biotech Co Ltd's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see balance sheet size of Taiyen Biotech Co Ltd.
Taiyen Biotech Co Ltd Competitors by Total Liabilities
The table below lists competitors of Taiyen Biotech Co Ltd ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Bossa Ticaret ve Sanayi Isletmeleri TAS
IS:BOSSA
|
Turkey | TL4.25 Billion |
|
Wei Chuan Foods Corp
TW:1201
|
Taiwan | NT$10.66 Billion |
|
Thien Long Group Corp
VN:TLG
|
Vietnam | ₫1.04 Trillion |
|
Hillgrove Resources Ltd
AU:HGO
|
Australia | AU$52.83 Million |
|
Hwacom Systems
TWO:6163
|
Taiwan | NT$4.06 Billion |
|
Vestel Beyaz Esya Sanayi ve Ticaret AS
IS:VESBE
|
Turkey | TL42.50 Billion |
|
STILLFRONT GRP AB SK-07
F:1YS0
|
Germany | €7.04 Billion |
|
Orient Group Inc
SHG:600811
|
China | CN¥19.23 Billion |
Liability Composition Analysis (2003–2025)
This chart breaks down Taiyen Biotech Co Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Taiyen Biotech Co Ltd (1737) net asset quality to measure how much of total assets are equity-financed.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.48 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.25 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Taiyen Biotech Co Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Taiyen Biotech Co Ltd (2003–2025)
The table below shows the annual total liabilities of Taiyen Biotech Co Ltd from 2003 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | NT$1.45 Billion ≈ $45.64 Million |
-15.45% |
| 2024-12-31 | NT$1.71 Billion ≈ $53.99 Million |
-3.24% |
| 2023-12-31 | NT$1.77 Billion ≈ $55.79 Million |
+14.27% |
| 2022-12-31 | NT$1.55 Billion ≈ $48.83 Million |
-20.70% |
| 2021-12-31 | NT$1.95 Billion ≈ $61.57 Million |
+36.33% |
| 2020-12-31 | NT$1.43 Billion ≈ $45.16 Million |
-1.05% |
| 2019-12-31 | NT$1.45 Billion ≈ $45.64 Million |
+23.77% |
| 2018-12-31 | NT$1.17 Billion ≈ $36.87 Million |
-4.74% |
| 2017-12-31 | NT$1.23 Billion ≈ $38.71 Million |
+15.14% |
| 2016-12-31 | NT$1.07 Billion ≈ $33.62 Million |
+7.77% |
| 2015-12-31 | NT$990.08 Million ≈ $31.19 Million |
+8.42% |
| 2014-12-31 | NT$913.15 Million ≈ $28.77 Million |
+109.12% |
| 2013-12-31 | NT$436.66 Million ≈ $13.76 Million |
+27.49% |
| 2012-12-31 | NT$342.49 Million ≈ $10.79 Million |
-3.94% |
| 2011-12-31 | NT$356.53 Million ≈ $11.23 Million |
-3.47% |
| 2010-12-31 | NT$369.36 Million ≈ $11.64 Million |
+12.23% |
| 2009-12-31 | NT$329.10 Million ≈ $10.37 Million |
+7.40% |
| 2008-12-31 | NT$306.42 Million ≈ $9.65 Million |
-16.72% |
| 2007-12-31 | NT$367.92 Million ≈ $11.59 Million |
-25.99% |
| 2006-12-31 | NT$497.10 Million ≈ $15.66 Million |
-46.31% |
| 2005-12-31 | NT$925.79 Million ≈ $29.17 Million |
-53.50% |
| 2004-12-31 | NT$1.99 Billion ≈ $62.73 Million |
-52.17% |
| 2003-12-31 | NT$4.16 Billion ≈ $131.13 Million |
-- |
About Taiyen Biotech Co Ltd
Taiyen Biotech Co., Ltd. engages in the production and sale of salt products in Taiwan and internationally. It offers seawater chemicals; toothpaste, mouthwashes, and eyeglass solutions; beverages; bottled water; medical supplies; food and food additives; beauty, skincare, and cleaning products; and salt products; as well as health food and health products. The company was founded in 1952 and is … Read more